Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Endocrinology and Metabolism|September 5, 2003
Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic probandD Tripathy, E Lindholm, B Isomaa, et al.
Acta Diabetologica|April 1, 1994
The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patientsC Saloranta, L Groop, A Ekstrand, et al.
Diabetologia|November 7, 1999
Heritability of albumin excretion rate in families of patients with Type II diabetesC M Forsblom, T Kanninen, M Lehtovirta, et al.
The American Journal of Physiology|May 1, 1991
Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sourcesH Yki-Järvinen, I Puhakainen, C Saloranta, et al.
Metabolism: Clinical and Experimental|July 1, 1992
Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in manA Ekstrand, C Saloranta, J Ahonen, et al.
Diabetologia|June 1, 1991
Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitusC Saloranta, A Franssila-Kallunki, A Ekstrand, et al.
Diabetes|November 1, 1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDMC Saloranta, M R Taskinen, E Widen, et al.
Diabetologia|April 1, 1988
Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agentsS Stenman, P H Groop, C Saloranta, et al.
Clinical Nephrology|April 1, 1986
The usefulness of micro- and macrochromatographic determinations of glycohemoglobin in diabetic patients with nephropathyC Saloranta, L Groop, K Ylinen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1993
Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetesC Saloranta, L Groop, A Ekstrand, et al.
Pageof 3